BLTEBelite Bio, Inc
Is it safe?
Caution warranted: heavy debt (CCC) and big price swings.
Insiders were net sellers (-$32.1M, 90 days to Oct 8, 2026), selling is often routine.
Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -75% · now 20% below its 52-week high.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can BLTE take a bad year?
The deepest fall in BLTE's price history on file is −75%; it is 20% below its high today.
Worst drawdown on file · −20% today
- Cash runway
- 5+ years
Cash runway · burning $9.3M a quarter at the current rate
- Annualised volatility
- 54%
Annualised volatility · roughly twice as jumpy as the market
Details›
- Cash and short-term investments
- $353M
- EBITDA, trailing twelve months
- −$84M
- Operating profit, trailing twelve months
- −$84M
- Annualised volatilitytwo years of daily moves
- 54%
- Worst drawdown on file
- −75%
- Below its 52-week high
- 20%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.